Kenta Inomata, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pyrrolizidine Alkaloids | 1 | 2018 | 10 | 0.640 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2018 | 96 | 0.590 |
Why?
|
| Liver Regeneration | 1 | 2018 | 214 | 0.550 |
Why?
|
| Living Donors | 1 | 2020 | 647 | 0.500 |
Why?
|
| Regenerative Medicine | 1 | 2018 | 306 | 0.480 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2018 | 523 | 0.450 |
Why?
|
| Carcinoma, Papillary | 1 | 2018 | 791 | 0.410 |
Why?
|
| Liver Transplantation | 2 | 2020 | 2416 | 0.350 |
Why?
|
| Liver | 3 | 2020 | 7578 | 0.300 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2330 | 0.290 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2018 | 1759 | 0.270 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 4357 | 0.230 |
Why?
|
| Pancreatic Neoplasms | 2 | 2019 | 5446 | 0.220 |
Why?
|
| Seawater | 2 | 2011 | 126 | 0.180 |
Why?
|
| Therapeutics | 1 | 2020 | 113 | 0.170 |
Why?
|
| Hepatocytes | 2 | 2018 | 1247 | 0.160 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2020 | 305 | 0.150 |
Why?
|
| Cyclin D1 | 1 | 2018 | 453 | 0.130 |
Why?
|
| Ki-67 Antigen | 1 | 2018 | 630 | 0.130 |
Why?
|
| Swine, Miniature | 1 | 2018 | 972 | 0.130 |
Why?
|
| Hepatectomy | 1 | 2018 | 589 | 0.120 |
Why?
|
| Phylogeny | 2 | 2011 | 2840 | 0.110 |
Why?
|
| Gammaproteobacteria | 1 | 2011 | 28 | 0.100 |
Why?
|
| Flavobacteriaceae | 1 | 2011 | 8 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2020 | 9410 | 0.090 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 1959 | 0.080 |
Why?
|
| Esophageal Neoplasms | 1 | 2019 | 1661 | 0.080 |
Why?
|
| Swine | 1 | 2018 | 5987 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 10748 | 0.070 |
Why?
|
| Survival Rate | 1 | 2020 | 12823 | 0.060 |
Why?
|
| Neoplasm Staging | 1 | 2020 | 11217 | 0.060 |
Why?
|
| Electroplating | 1 | 2003 | 7 | 0.060 |
Why?
|
| Water Pollutants | 1 | 2003 | 25 | 0.060 |
Why?
|
| Tissue Engineering | 1 | 2014 | 1861 | 0.060 |
Why?
|
| Water Purification | 1 | 2003 | 61 | 0.050 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2014 | 1665 | 0.050 |
Why?
|
| Metals, Heavy | 1 | 2003 | 149 | 0.050 |
Why?
|
| Heterotrophic Processes | 2 | 2011 | 5 | 0.050 |
Why?
|
| Pacific Ocean | 2 | 2011 | 16 | 0.050 |
Why?
|
| Base Composition | 2 | 2011 | 291 | 0.050 |
Why?
|
| Bacterial Typing Techniques | 2 | 2011 | 263 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 974 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18330 | 0.040 |
Why?
|
| Time Factors | 1 | 2020 | 40154 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 2815 | 0.040 |
Why?
|
| Splenectomy | 1 | 2019 | 390 | 0.040 |
Why?
|
| Prognosis | 1 | 2018 | 29963 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2011 | 1044 | 0.030 |
Why?
|
| Japan | 2 | 2011 | 1418 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 65295 | 0.030 |
Why?
|
| DNA, Bacterial | 2 | 2011 | 1477 | 0.030 |
Why?
|
| Esophagectomy | 1 | 2019 | 478 | 0.030 |
Why?
|
| Endosonography | 1 | 2019 | 626 | 0.030 |
Why?
|
| Middle Aged | 2 | 2020 | 223233 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2019 | 825 | 0.030 |
Why?
|
| Fatty Acids | 2 | 2011 | 1806 | 0.030 |
Why?
|
| Female | 4 | 2020 | 396660 | 0.030 |
Why?
|
| Lymph Node Excision | 1 | 2019 | 1267 | 0.030 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2014 | 254 | 0.020 |
Why?
|
| Pancreas | 1 | 2019 | 1699 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2014 | 1168 | 0.020 |
Why?
|
| Vitamin K 2 | 1 | 2011 | 47 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2020 | 81659 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2209 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2019 | 2900 | 0.020 |
Why?
|
| Water Microbiology | 1 | 2011 | 117 | 0.020 |
Why?
|
| Monocytes | 1 | 2020 | 2598 | 0.020 |
Why?
|
| Pigmentation | 1 | 2011 | 143 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 4780 | 0.020 |
Why?
|
| Animals | 3 | 2018 | 168965 | 0.020 |
Why?
|
| Cell Count | 1 | 2014 | 1825 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2020 | 2745 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 223317 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 17608 | 0.020 |
Why?
|
| Humans | 4 | 2020 | 767040 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2014 | 1612 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3468 | 0.020 |
Why?
|
| Phospholipids | 1 | 2011 | 778 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 2412 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2014 | 938 | 0.020 |
Why?
|
| Refuse Disposal | 1 | 2003 | 31 | 0.010 |
Why?
|
| Male | 2 | 2020 | 364203 | 0.010 |
Why?
|
| Adsorption | 1 | 2003 | 198 | 0.010 |
Why?
|
| Remission Induction | 1 | 2007 | 2408 | 0.010 |
Why?
|
| Cost Control | 1 | 2003 | 627 | 0.010 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1515 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 8108 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 20741 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 59548 | 0.010 |
Why?
|
| Rats | 1 | 2007 | 23713 | 0.010 |
Why?
|